Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

B-type Natriuretic Peptide (BNP) as a Predictive Marker after Heart Transplantation

심장이식 후 예측인자로서 B-type Natriuretic Peptide (BNP)의 역할

  • Shin, Hong-Ju (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Hee-Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choo, Suk-Jung (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Jae-Joong (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Meong-Gun (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • 신홍주 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 김희중 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 주석중 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 김재중 (울산대학교 의과대학 서울아산병원 흉부외과학교실) ;
  • 송명근 (울산대학교 의과대학 서울아산병원 흉부외과학교실)
  • Published : 2007.08.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: B-type natriuretic peptide (BNP) is a cardiac hormone that is primarily synthesized by the ventricular cardiac myocytes. Increased plasma BNP levels have been observed in patients suffering with congestive heart failure, ventricular hypertrophy and myocaridits and also during heart transplantation rejection. We investigated the serum BNP level as a predictive marker for rejection after heart transplantation. Material and Method: To test the usefulness of measuring the BNP level in cardiac transplant patients, consecutive blood samplings for BNP, right ventricular endomyocardial biopsies, hemodynamic measurements and transthoracic echocardiogram were all done in 10 such patients between January 2004 and August 2005 at the Department of Thoracic and Cardiovascular Surgery in Asan Medical Center. Two groups were identified with using the median value: the low BNP group (n=28, BNP: ${\le}290$ pg/mL) and the high BNP group (n=29, BNP: >290 pg/mL). We retrospectively analyzed rejection, the ejection fraction, tricuspid regurgitation, left ventricular hypertrophy, the pulmonary capillary wedge pressure and the right atrial pressure between the 2 groups. Result: There were no differences in age, gender, rejection, the ejection fraction, tricuspid regurgitation, left ventricular hypertrophy and the right atrial pressure between the 2 groups (p>0.05). However, a higher pulmonary capillary wedge pressure and a higher mean pulmonary atrial pressure were observed in the high BNP group (p<0.05). Further, BNP has linear correlation with the pulmonary capillary wedge pressure (r=0.590, p<0.001). Using the cut-off value of 620 pg/mL, the BNP predicted a high PCWP (>12 mmHg) with a sensitivity of 83.3% and a specificity of 91.1% (AUC: $0.900{\pm}0.045$, p<0.001). Conclusion: The BNP level after heart transplantation does not show any significant correlation with rejection, yet it might be a predictive marker of ventricular diastolic dysfunction.

배경: B-type natriuretic peptide (BNP)는 심실 심근 세포에서 생성되는 심장 호르몬이며, 울혈성 심부전, 심실비대증, 심근염, 심장이식 후 거부반응 때 증가하는 것으로 알려져 있다. 본 연구에서는 심장이식 후 거부 반응의 예측 인자로서의 BNP의 역할에 대해 조사하였다. 대상 및 방법: 심장이식을 받은 10명의 환자를 대상으로 하여 2004년 1월부터 2005년 8월까지 BNP측정값, 심내막 생검을 통한 거부반응, 혈역학적 지표, 심초음파 검사 결과 등을 조사하였으며, 57예의 BNP 측정값의 중간값인 290 pg/mL를 기준으로 하여 Low BNP (n=28, $BNP{\le}290$ pg/mL)군, High BNP (n=29, BNP>290 pg/mL)군으로 나누어 거부반응의 정도, 좌심실구혈률, 삼첨판막 폐쇄 부전, 좌심실비대, 폐동맥쐐기압, 평균 폐동맥압, 우심방압을 후향적으로 비교 분석하였다. 결과: BNP값의 차이에 따른 양 군 간심내막생검에 따른 거부반응의 정도, 좌심실구혈률, 삼첨판막 폐쇄 부전, 좌심실비대, 우심방압은 통계학적으로 유의한 차이가 없었다(p>0.05). 그러나, High BNP군에서 폐동맥쐐기압, 평균 폐동맥압이 Low BNP군보다 높았으며(p<0.05), BNP 측정값은 폐동맥쐐기압과 의미 있는 양의 상관관계를 보였다(r=0.590, p<0.001). BNP 측정값 620 pg/mL를 기준으로 했을때, 폐동맥쐐기압은 83.3%의 민감도와 91.1%의 특이도를 보이며 12 mmHg보다 높은 값을 보였다(AUC: $0.900{\pm}0.045$, p<0.001). 결론: 심장이식 후 BNP 측정값은 거부반응의 정도와 의미 있는 상관관계를 보이지는 않았으나, 심실의 이완기 불능 상태를 평가하는 유용한 지표가 될 수 있다.

Keywords

References

  1. Bernard CN. Human cardiac transplantation. An evaluation of the first two operations performed at the Groote Schuur Hospital, Cape Town. Am J Cardiol 1968;22:584-96 https://doi.org/10.1016/0002-9149(68)90166-5
  2. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990;9:587-93
  3. Nealson H, Soerensen FB, Neilsen B. Reproducibility of acute rejection diagnosis in human cardiac allograft: the Stanford classification of the international grading system. J Heart Lung Transplant 1993;12:239-43
  4. Hosenpud JD. Noninvasive diagnosis of cardiac allograft rejection: another of the many searches for the grail. Circulation 1992;85:368-72 https://doi.org/10.1161/01.CIR.85.1.368
  5. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13 https://doi.org/10.1016/S0140-6736(97)03034-1
  6. El Gamel A, Yonan NA, Keevil B, et al. Significance of raised natriuretic peptides after bicaval and standard cardiac transplantation. Ann Thorac Surg 1997;63:1095-100 https://doi.org/10.1016/S0003-4975(97)00168-9
  7. Masters RG, Davies RA, Veinot JP, Hendry PJ, Smith SJ, de Bold AJ. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans. Circulation 1999;100:287-91 https://doi.org/10.1161/01.CIR.100.3.287
  8. Almenar L, Hervas I, Martinez-Dolz L, et al. The value of brain natriuretic peptide for the diagnosis of heart transplant rejection. Transplant Proc 2002;34:174-5 https://doi.org/10.1016/S0041-1345(01)02716-6
  9. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Cli Chem 1993;39:561-77
  10. Jignesh KP, Jon AK. Should we be doing routine biopsy after heart transplantation in a new era of antirejection? Curr Opin Cardiol 2006;21:127-31 https://doi.org/10.1097/01.hco.0000210309.71984.30
  11. Sun JP, Abdalla IA, Asher CR, et al. Non-invasive evaluation of orthotopic heart transplant rejection by echocardiography. J Heart Lung Transplant 2005;24:160-5 https://doi.org/10.1016/j.healun.2003.11.400
  12. Marie PY, Angioï M, Carteaux JP, et al. Detection and prediction of acute heart transplantation rejection with the myopcardial T2 determination provided by a blackblood magnetic resonance imaging sequence. J Am Coll Cardiol 2001;37:825-31 https://doi.org/10.1016/S0735-1097(00)01089-5
  13. Ationu A, Burch M, Singer D, Littleton P, Carter N. Cardiac transplantation affects ventricular expression of brain natriuretic peptide. Cardiovasc Res 1993;27:188-91 https://doi.org/10.1093/cvr/27.2.188
  14. Lindbalde CL, Chun DS, Darragh RK, Caldwell RL, Murphy DJ, Schamberger MS. Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients. Am J Cardiol 2005;95:909-11 https://doi.org/10.1016/j.amjcard.2004.11.054
  15. Mehra MR, Uber PA, Potluri S, Ventura HO, Scott RL, Park MH. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am J Cardiol 2004;94:454-8 https://doi.org/10.1016/j.amjcard.2004.04.060
  16. Park MH, Scott RL, Uber PA, Harris BC, Chambers R, Mehra MR. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am J Cardiol 2002;90;1326-9 https://doi.org/10.1016/S0002-9149(02)02871-0
  17. Davies RA, Koshal A, Walley V, et al. Temporary diastolic noncompliance with preserved systolic function after heart transplanatation. Transplant Proc 1987;4:3444-7